| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_942782ef91e65ecc67141721d44d38eb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate |
2019-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ef91413d3cecc75ea8e538eec6d1e27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99cfe327659e4c0745ead12000cf9db0 |
| publicationDate |
2020-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-102147600-B1 |
| titleOfInvention |
The polymorph of a novel dabigatran etexilate hemi-salt and the manufacturing method thereof |
| abstract |
The present inventors of the present invention are dabigatran etexilate hemiedecylate, a new dabigatran etexilate salt with improved low water solubility and thermal stability of the currently commercially available dabigatran etexilate methanesulfonate, and a polymorph thereof. It provides a coagulation inhibitor and a pharmaceutical composition for the treatment of stroke and systemic embolism in patients with non-membrane atrial fibrillation. |
| priorityDate |
2019-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |